The FDA pulls key DEI initiative for cancer studies from its website

The Food and Drug Administration has removed webpages about diversity and inclusion in clinical trials for cancer drugs.

The page for Project Equity, a 2021 initiative launched by the FDA's Oncology Center of Excellence to ensure that cancer drugs were evaluated for approval based on data from a diverse group of study participants, has gone dark.